Differential display (DD) is widely employed for identifying uniquely expressed genes within two different cell populations. While potentially powerful, DD is problematic because apparent positive clones require time-consuming verification which may be made even more difficult if only small amounts of starting material are available. We have devised a screening approach to address these issues in primary human hematopoietic cells. Candidate clones are identified in a slot-blot format and verified by 'Virtual Northern' blot analyses using globally amplified cDNA as the verification probe. This method is fast, and since it requires only ෂ0.2 g of total RNA, it is particularly useful when only limited amounts of study tissue are available.
Introduction
Differential gene expression regulates many biological processes central to cell growth, and development. Tools permitting detection and identification of differentially expressed genes would clearly be of enormous value and a number of methodologies have been developed for this purpose. Such techniques include differential display (DD), 1, 2 subtractive hybridization 3 and representational difference analysis (RDA). 4 Each of these methods is powerful, but all are somewhat problematic because of high false positive rates which necessitate additional screening and verification of clones of interest. 5 Screening strategies which seek to address the problem of false positives have been developed. 6, 7 In essence, candidate clones are arrayed on duplicate slot-blot membranes and probed with radio-labeled cDNA generated by reverse transcription of the two RNA samples to be compared. This method is relatively rapid and significantly reduces verification time. However, a major limitation of this approach is that generating the cDNA probe requires 10-50 g of total RNA. It is not always possible to obtain RNA in these amounts when biopsy specimens, embryos, or rare cells constitute the study materials. identifying genes which are differentially expressed between normal human megakaryocytes and other hematopoietic cells in the bone marrow. Megakaryocytes, the cellular precursors of blood platelets, are rare among nucleated bone marrow cells (ෂ0.05% as defined by morphological criteria). FACS sorting allows collection of 2 × 10 5 to 2 × 10 6 megakaryocytes from 15 ml of liquid marrow. This number of cells yields at most 4 g of total RNA. To perform DD with this quantity of material, and to ensure the ability to rapidly verify potentially positive clones, we have developed a screening method employing globally amplified cDNA probes. The method is rapid, highly reproducible, and equally appropriate for differential screening of clones generated by subtractive hybridization and RDA.
Materials and methods
Light density bone marrow mononuclear cells (LDMNC) were isolated as previously described. 8 LDMNC belonging to the megakaryocyte lineage were defined as the brightest 5% of cells expressing platelet glycoprotein IIb on their surface. 9 These IIb + cells were isolated from the other LDMNC (IIb − ) by fluorescence-activated cell sorting (FACStar; Becton Dickinson, San Jose, CA, USA). Total RNA from sorted IIb + and IIb − cells was extracted using a modified single-step guanidium denaturation method 10 (Ultraspec RNA isolation system; Biotecx Laboratories, Houston, TX, USA). To eliminate genomic DNA contamination, samples were digested with 1 U RQ1-DNase/g RNA (Promega, Madison, WI, USA) at 37°C for 15 min followed by phenol chloroform extraction and ethanol precipitation. Differential display was performed with RNAimage Kit 1 mRNA differential display system from GenHunter (Nashville, TN, USA). 2 Each of the three reverse transcription reactions using T 11 G, T 11 A and T 11 C primers utilized 0.10 g of total RNA. Differentially expressed bands were excised, re-amplified, subcloned into pGEMT vector (Promega), and transformed into DH5␣ (Gibco-BRL Life Technology, Gaithersburg, MD, USA) according to standard procedure. 11 To generate globally amplified cDNA probes from the IIb + and IIb − cell populations, 0.2 g of DNase-treated RNA was reverse transcribed and PCR amplified using the SMART cDNA synthesis technology (Clontech, Palo Alto, USA) 12 according to the vendor's instructions. In brief, total RNA was primed with 1 M of cDNA synthesis primer (CDS primer; 5ЈAAGCAGTGGTATCAACGCAGAGTACT 30 N −1 N-3Ј), reverse transcribed with 200 U MMLV reverse transcriptase 10 l volume at 42°C for 1 h. When the enzyme reaches the end of the mRNA, the endogenous terminal transferase activity adds a few additional deoxycytidine residues. 13 This dC stretch pairs with the oligo dG at the 3Ј end of the SMART oligonucleotide (5Ј-AAGCAGTGGTATCAACGCAGAGTACGCGGG-3Ј). Reverse transcriptase then switches templates and extends to the end of the SMART oligonucleotide. First-strand cDNA corresponding to 20 ng of the starting RNA was PCR amplified with 1 × Advantage KlenTaq polymerase mix (1.1 g of KlenTaq-1 DNA polymerase and TaqStart Antibody; Clontech) using 0.2 M of dNTP and 1 M of amplification primer with sequence corresponding to the 5Ј end in both the CDS and SMART oligos (5Ј-AAGCAGTGGTATCAACGCAGAGT-3Ј) in 1 × KlenTaq PCR buffer (40 mM Tricine-KOH, 15 mM KOAc, 3.5 mM Mg (OAc) 2 , 75 g/mL BSA). Long-distance PCR was performed at 95°C for 15 s and 68°C for 5 min for 20 to 22 cycles (the optimal cycle number) in a Perkin Elmer DNA Thermal Cycler 480 (Perkin Elmer-Cetus, Norwalk, CT, USA).
Preliminary experiments were performed to determine the optimal cycle number which yielded exponential amplification with near maximal product. The PCR reactions were purified with the Qiaquick PCR purification column (Qiagen, Chatsworth, CA, USA). The amplified cDNA generated from 0.2 g of RNA is enough for 25 slot-blot screenings or 'Virtual Northern' analyses (see below). Purified cDNA (0.5 g) was radiolabeled with ␣-32 P-dCTP by random priming 14 using Ready to Go DNA labeling beads (Pharmacia Biotech, Piscataway, NJ, USA). Candidate clones to be screened were randomly picked (six colonies per differentially expressed band) and expanded in 30 l of LB/Amp for 6 h. The inserts from the clones were then amplified by PCR using 2 l of bacterial culture, 0.2 M each of the T7 promoter primer and Sp6 pro- PCR products (2.5 l of the total reaction) were analyzed on agarose gels to ensure the successful amplification of each clone. The remaining products (22.5 l) were diluted with 200 l of 0.5 N NaOH/12.5 mM EDTA and denatured at 95°C for 10 min. One hundred l of denatured DNA was applied on to duplicate GeneScreenPlus Nylon membranes (3 × 4.5 in, DuPont NEN Research Products, Boston, MA, USA) using a 48-slot blotting apparatus (Bio-Dot, Bio-Rad, Hercules, CA, USA). The membranes were rinsed in 2 × SSC and UVcrosslinked in a Stratalinker (Stratagene, La Jolla, CA, USA). Seven million c.p.m. of each cDNA probe was denatured and hybridized to the duplicate membranes in 7.5 ml of hybridization solution (50% formamide, 4 × SSC, 5 × Denhardt, 0.1% SDS, 10% dextran sulfate, 1 mM EDTA (pH 8.0), 100 g/ml denatured salmon sperm DNA) at 42°C overnight. Membranes were then washed once in 2 × SSC/0.05% SDS at room temperature for 20 min, twice in 0.1 × SSC/0.1% SDS at 65°C for 20 min then exposed to X-ray films.
Differentially expressed clones as defined by the slot-blot screening were further verified by 'Virtual Northern' blot analysis. In this assay, SMART amplified cDNA from the two populations was fractionated on a 1% agarose gel, transferred to a nylon membrane, and hybridized to the cDNA insert of the clone to be verified. After autoradiography, the same blot was stripped by boiling in 0.5% SDS for 10 min and reprobed with the full length ␤-actin cDNA. Only clones that were consistently positive on both slot-blot and 'Virtual Northern' were expanded, sequenced and further verified by semi-quantitative RT-PCR.
Results and discussion
Results of a SMARTcDNA synthesis, slot-blot screening, and 'Virtual Northern' blot verification of a representative clone are shown in Figure 1 . The amplified cDNAs from the two cell populations consist of fragments from 200 bp to 3 kb indicating that significant portion of the products were near full length (Figure 1a) . Slot blot screening is illustrated in Figure  1b . Clones 3-1a and 28-3b were not differentially expressed. 'Virtual Northern' blot analysis was carried out to verify that clone 11-1d was differentially expressed in the IIb ϩ cells (Figure 1c ). This step is critical because clones may be identified as being differentially expressed in the slot-blot screening that will fail to give differential signals in the 'Virtual Northern' (data now shown). Therefore potentially misleading, and noninformative RT-PCR reactions are avoided. Semi-quantitative RT-PCR further confirmed that the message level of 11-1d is three-to six-fold in megakaryocytes vs non-megakaryocytes.
The minimal amount of RNA necessary for the entire screening process (including DD, slot-blot screening, 'Virtual Northern', and RT-PCR) can be lowered to 0.6 g if only a few RT-PCRs are to be performed but further reductions should be avoided since lesser amounts of RNA lead to loss of reproducibility. We have also successfully applied this screening procedure to clones derived from subtractive hybridization (manuscript submitted).
As noted above, a number of strategies for detecting differentially expressed genes in rare cell populations have been reported. [15] [16] [17] [18] Ross et al 15 reported a screening strategy similar to the one we report using cDNA amplified from adaptor-ligated ds cDNA. The method described here has several advantages over the method of Ross et al in that isolation of polyA RNA was not necessary for our cDNA amplifications. Far less RNA was therefore required. In addition, long-distance PCR employed in SMART cDNA synthesis resulted in more fulllength cDNA fragments. This is an important feature for screening clones derived from subtractive hybridization and RDA since most clones do not correspond to the 3Ј ends of the messages. Another important issue is representation of low level or rare messages. Our work, and the work of others [16] [17] [18] suggest that such messages are likely to be represented in cDNA generated by the strategy described above. Whether 'all' such messages will be present is uncertain. By employing this screening scheme then, we have saved significant amounts of time and money, by avoiding unnecessary mini-preps, sequencing and RT-PCR reactions. For these reasons, we believe this high throughput screening method is a significant improvement over existing ones and would be helpful to investigators working with scarce materials.
